Author:
Liao Jun,Yang Fan,Zhang Lei,Chai Xiaoyun,Zhao Qingjie,Yu Shichong,Zou Yan,Meng Qingguo,Wu Qiuye
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference32 articles.
1. Akhter, M., A. Husain, B. Azad, and M. Ajmal. 2009. Aroylpropionic acid based 2,5-disubstituted-1,3,4-oxadiazoles: Synthesis and their anti-inflammatory and analgesic activities. European Journal of Medicinal Chemistry 44: 2372–2378.
2. Casalinuovo, I.A., P. Di Francesco, and E. Garaci. 2004. Fluconazole resistance in Candida albicans: A review of mechanisms. European Review for Medical and Pharmacological Sciences 8: 69–77.
3. Cha, R., and J.D. Sobel. 2004. Fluconazole for the treatment of candidiasis: 15 years’ experience. Expert Review of Anticancer Therapy 2: 357–366.
4. Chai, X.Y., J. Zhang, H.G. Hu, S.C. Yu, Q.Y. Sun, D.Z. Zhang, and Q.Y. Wu. 2009. Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase. European Journal of Medicinal Chemistry 44: 1913–1920.
5. Chakrabarti, A. 2005. Microbiology of systemic fungal infections. Journal of Postgraduate Medicine 51: S16–S20.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Iodine and DMSO as Surrogate of Hazardous Metal and Non‐Metal Reagents in Organic Synthesis;ChemistrySelect;2024-01-17
2. Synthesis, Antitubercular, and Antifungal Activity of 2-(trifluoromethyl)-3-(substituted phenyl-1,3,4-oxadiazol-2-yl)-pyridine;Russian Journal of Bioorganic Chemistry;2023-12
3. Strategies of targeting CYP51 for IFIs therapy: Emerging prospects, opportunities and challenges;European Journal of Medicinal Chemistry;2023-11
4. 1,3,
4‐oxadiazole
derivatives as potential antimicrobial agents;Chemical Biology & Drug Design;2022-06-27
5. Cholyl 1,3,4-oxadiazole hybrid compounds: design, synthesis and antimicrobial assessment;Beilstein Journal of Organic Chemistry;2022-05-31